Author

A. Mammen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:CITE-seq· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Assay:DNA methylation· 1

Frequent Co-Authors

I. Pinal-Fernandez· 2 shared A. J. Martins· 1 shared A. Rajan· 1 shared A. S. Grewel· 1 shared C. V. Sundar-Raj· 1 shared C. Zhao· 1 shared D. K. Dhaliwal· 1 shared E. G. Romanowski· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

I. Pinal-Fernandez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Rise in frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021

R. M. Q. Shanks, S. Atta, N. A. Stella, C. V. Sundar-Raj, J. E. Romanowski, A. S. Grewel, H. Q. Shanks, S. M. Mumper, D. K. Dhaliwal, A. Mammen, J. D. Callaghan, R. C. Calvario, E. G. Romanowski, R. P. Kowalski, M. E. Zegans, V. Jhanji

The paper tracks the rise in lasR mutations in Pseudomonas aeruginosa keratitis isolates from 1993 to 2021, showing increased frequency and association with worse clinical outcomes.

bioRxiv · Aug 22, 2023 · PreprintMicrobiology

Contrasting autoimmune and treatment effects reveals baseline set points of immune toxicity following checkpoint inhibitor treatment

C. Zhao, M. P. Mule, A. J. Martins, I. Pinal-Fernandez, R. N. Donahue, J. Chen, J. Schlom, J. L. Gulley, A. Mammen, J. S. Tsang, A. Rajan

The paper identifies pre-treatment immune signatures associated with immune-related adverse events (irAEs) in thymic cancer patients receiving checkpoint inhibitors using CITE-seq.

bioRxiv · Jun 5, 2022 · PreprintImmunology

Ultra-Efficient Short Read Sequencing of T Cell Receptor Repertoires

J. Montagne, X. Zheng, I. Pinal-Fernandez, J. Milisenda, L. Christopher-Stine, T. Lloyd, A. Mammen, H. B. Larman

This paper introduces FR3AK-seq, a cost-effective method for TCR CDR3 repertoire analysis, showing it is sensitive and comparable to industry standards.

bioRxiv · Feb 5, 2020 · PreprintImmunology